Poland· PL-100416370
Alunbrig
A brigatinib product containing brigatinibum, registered in Poland by Takeda Pharma A/S. The same ATC class is registered in 13 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Brigatinib is registered in 13 of 19 countries.
Countries holding a registration under ATC L01ED04 (brigatinib), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Brigatinib · ATC L01ED04
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of brigatinib costs, country by country.
Normalised to the WHO defined daily dose (0.18 g), the median price runs from $16.82 in Czechia to $204.41 in Switzerland — a ×12 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Brigatinib · price per daily dose (0.18 g)
USD · FX 28 Sept 2026
- CH Switzerland$204.41
- FR France$112.63
- CZ Czechia$16.82
The record
At a glance
URPL (Poland)- Active substance
- Brigatinibum
- Manufacturer
- Takeda Pharma A/S
- Country
- Poland (PL)
- ATC code
- L01ED04
- ATC class
- Brigatinib
- Defined daily dose
- 0.18 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin07038319119970
- gtin07046264510094
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
576 interactions on record for brigatinib.
Graded by severity as the source publishes them — 126 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Brigatinib · interactions on record
576 records
- 126 severe
- 442 moderate
- 8 minor
Most severe, free to view
- AprepitantA04AD12severe
- LonafarnibA16AX20severe
- VoxelotorB06AX03severe
- DronedaroneC01BD07severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Brigatinib in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaALUNBRIGTakeda Pharma A/S, Vallensbaek Strand
- SwitzerlandAlunbrig
- FinlandAlunbrigTakeda Pharma A/S
- FranceALUNBRIG 30 mg, comprimé pelliculéTAKEDA PHARMA (DANEMARK)
- IrelandAlunbrig 30 mg film-coated tabletsTakeda Pharma A/S
- IcelandAlunbrigTakeda Pharma A/S
- NetherlandsAlunbrig 30 mg, filmomhulde tabletAriad Pharma Ltd
- NorwayAlunbrigTakeda Pharma A/S (1)
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Alunbrig
- Liechtenstein · Alunbrig
- Norway · Alunbrig
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2f3f893c-191e-44e5-88de-760b441da34d GET /v1/drugs/2f3f893c-191e-44e5-88de-760b441da34d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "30 mg",
"packaging": "Rpz ¦ EU/1/18/1264/003 ¦ 131235\n56 tabl.\nRpz ¦ EU/1/18/1264/001 ¦ 131236\n60 tabl.\nRpz ¦ EU/1/18/1264/004 ¦ 131237\n112 tabl.\nRpz ¦ EU/1/18/1264/002 ¦ 131238\n120 tabl.\n07038319119970 ¦ Rpz ¦ EU/1/18/1264/011 ¦ 131362\n28 tabl.\n¦ UR/Z/4c/026/21 - 07046264510094 ¦ UR/Z/4c/113/22 - 07046264510094",
"substance": "Brigatinibum 30 mg",
"common_name": "Brigatinibum",
"pl_product_id": "100416370",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about brigatinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.